BRIDGEWAY CAPITAL MANAGEMENT, LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$42,000
-61.1%
107,050
-44.1%
0.00%
-50.0%
Q2 2022$108,000
-59.2%
191,450
-19.0%
0.00%
-60.0%
Q1 2022$265,000
-12.8%
236,450
+13.4%
0.01%
-16.7%
Q4 2021$304,000
-62.0%
208,450
-21.8%
0.01%
-60.0%
Q3 2021$799,000
+466.7%
266,450
+775.0%
0.02%
+400.0%
Q2 2021$141,000
-23.0%
30,4500.0%0.00%0.0%
Q1 2021$183,000
+14.4%
30,4500.0%0.00%0.0%
Q4 2020$160,00030,4500.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders